These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23323285)

  • 1. [Inhibitors of proton pump in the treatment of Zollinger-Ellison syndrome].
    Kubyshkin VA; Kochatkov AV
    Khirurgiia (Mosk); 2012; (12):67-71. PubMed ID: 23323285
    [No Abstract]   [Full Text] [Related]  

  • 2. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndrome.
    Nieto JM; Pisegna JR
    Expert Opin Pharmacother; 2006 Feb; 7(2):169-75. PubMed ID: 16433582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
    Sosnowski M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inhibitors of the proton pump].
    Portet-Brunet L
    Soins; 1993 May; (572):59-60. PubMed ID: 8303418
    [No Abstract]   [Full Text] [Related]  

  • 7. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: the clinical pharmacology of proton pump inhibitors.
    Sachs G; Shin JM; Howden CW
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():2-8. PubMed ID: 16700898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view.
    Pellicano R; De Angelis C; Resegotti A; Rizzetto M
    Panminerva Med; 2006 Mar; 48(1):33-40. PubMed ID: 16633330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton pump inhibitors and chronic requirement].
    Waldum HL
    Lakartidningen; 2003 May; 100(20):1830-1. PubMed ID: 12806870
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of acid-related disorders in the United States.
    Brown M; Yang RD
    Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors.
    Wilcox CM; Seay T; Arcury J; Hirschowitz BI
    Scand J Gastroenterol; 2011 Mar; 46(3):277-80. PubMed ID: 21073392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Zollinger-Ellison syndrome].
    Varas MJ
    Rev Med Univ Navarra; 1995; 39(4):18-23. PubMed ID: 9499838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
    Nishi T; Makuuchi H; Weinstein WM
    Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Vallot ; Mayeur S
    Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Omeprazole and inhibition of gastric acid secretion].
    Rossi G
    Recenti Prog Med; 1984 Apr; 75(4):419-21. PubMed ID: 6729204
    [No Abstract]   [Full Text] [Related]  

  • 19. Proton pump inhibitors and gastric neoplasia.
    Waldum HL; Qvigstad G
    Gut; 2007 Jul; 56(7):1019-20; author reply 1020. PubMed ID: 17566032
    [No Abstract]   [Full Text] [Related]  

  • 20. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
    Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L
    N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.